IHT Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.64M | Sell |
3,279
-253
| -7% | -$121K | 0.04% | 457 |
|
|
2026
Q1 | $1.74M | Sell |
3,532
-215
| -6% | -$117K | 0.04% | 416 |
|
|
2025
Q4 | $2.17M | Sell |
3,747
-941
| -20% | -$532K | 0.05% | 320 |
|
|
2025
Q3 | $2.27M | Sell |
4,688
-290
| -6% | -$135K | 0.06% | 305 |
|
|
2025
Q2 | $2.02M | Buy |
4,978
+1,694
| +52% | +$708K | 0.06% | 316 |
|
|
2025
Q1 | $1.63M | Sell |
3,284
-227
| -6% | -$123K | 0.05% | 333 |
|
|
2024
Q4 | $1.83M | Sell |
3,511
-456
| -11% | -$251K | 0.06% | 297 |
|
|
2024
Q3 | $2.45M | Buy |
3,967
+243
| +7% | +$144K | 0.07% | 274 |
|
|
2024
Q2 | $2.06M | Sell |
3,724
-21
| -0.6% | -$12K | 0.08% | 249 |
|
|
2024
Q1 | $2.18M | Sell |
3,745
-1,051
| -22% | -$590K | 0.09% | 234 |
|
|
2023
Q4 | $2.55M | Buy |
4,796
+314
| +7% | +$152K | 0.11% | 179 |
|
|
2023
Q3 | $2.27M | Buy |
4,482
+779
| +21% | +$415K | 0.12% | 178 |
|
|
2023
Q2 | $1.93M | Sell |
3,703
-66
| -2% | -$35.6K | 0.1% | 195 |
|
|
2023
Q1 | $2.17M | Buy |
3,769
+368
| +11% | +$207K | 0.12% | 160 |
|
|
2022
Q4 | $1.87M | Buy |
3,401
+26
| +0.8% | +$13.8K | 0.12% | 181 |
|
|
2022
Q3 | $1.71M | Buy |
3,375
+917
| +37% | +$513K | 0.13% | 182 |
|
|
2022
Q2 | $1.33M | Buy |
2,458
+84
| +4% | +$46.2K | 0.12% | 180 |
|
|
2022
Q1 | $1.4M | Sell |
2,374
-2
| -0.1% | -$1.15K | 0.11% | 195 |
|
|
2021
Q4 | $1.58M | Sell |
2,376
-51
| -2% | -$31.8K | 0.12% | 173 |
|
|
2021
Q3 | $1.39M | Sell |
2,427
-1,303
| -35% | -$715K | 0.11% | 181 |
|
|
2021
Q2 | $1.88M | Sell |
3,730
-24
| -0.6% | -$11.3K | 0.12% | 176 |
|
|
2021
Q1 | $1.71M | Buy |
3,754
+234
| +7% | +$112K | 0.12% | 174 |
|
|
2020
Q4 | $1.64M | Buy |
3,520
+211
| +6% | +$98.9K | 0.14% | 163 |
|
|
2020
Q3 | $1.46M | Buy |
3,309
+528
| +19% | +$218K | 0.15% | 147 |
|
|
2020
Q2 | $1.01M | Sell |
2,781
-362
| -12% | -$121K | 0.14% | 162 |
|
|
2020
Q1 | $891K | Sell |
3,143
-48
| -2% | -$15.1K | 0.13% | 180 |
|
|
2019
Q4 | $1.04M | Buy |
3,191
+122
| +4% | +$37K | 0.12% | 191 |
|
|
2019
Q3 | $894K | Buy |
3,069
+735
| +31% | +$210K | 0.12% | 193 |
|
|
2019
Q2 | $685K | Sell |
2,334
-493
| -17% | -$136K | 0.1% | 231 |
|
|
2019
Q1 | $774K | Sell |
2,827
-21
| -0.7% | -$5.23K | 0.13% | 186 |
|
|
2018
Q4 | $637K | Buy |
2,848
+594
| +26% | +$139K | 0.12% | 200 |
|
|
2018
Q3 | $550K | Sell |
2,254
-240
| -10% | -$55.2K | 0.12% | 218 |
|
|
2018
Q2 | $517K | Buy |
2,494
+251
| +11% | +$53.3K | 0.13% | 202 |
|
|
2018
Q1 | $456K | Buy |
2,243
+149
| +7% | +$31.3K | 0.12% | 198 |
|
|
2017
Q4 | $424K | Buy |
2,094
+5
| +0.2% | +$958 | 0.11% | 225 |
|
|
2017
Q3 | $404K | Sell |
2,089
-420
| -17% | -$76.1K | 0.17% | 142 |
|
|
2017
Q2 | $39 | Buy |
2,509
+536
| +27% | +$90K | 0.02% | 578 |
|
|
2017
Q1 | $301K | Sell |
1,973
-47
| -2% | -$7.18K | 0.2% | 126 |
|
|
2016
Q4 | $290K | Buy |
+2,020
| New | +$298K | 0.22% | 113 |
|
Other funds holding TMO
IHT Wealth Management's TMO Position: Q2 2026 in Review
IHT Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 7.2% in Q2 2026, selling an estimated $121K and leaving 3,279 shares worth $1.64M. The position accounts for 0.04% of the portfolio, ranked #457.
IHT Wealth Management first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.55M in Q4 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- IHT Wealth Management held 3,279 shares of Thermo Fisher Scientific worth $1.64M as of Q2 2026.
- IHT Wealth Management sold 253 Thermo Fisher Scientific shares in Q2 2026, an estimated $121K.
- Thermo Fisher Scientific made up 0.04% of IHT Wealth Management's portfolio in Q2 2026, its #457 holding.
- IHT Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- IHT Wealth Management's Thermo Fisher Scientific position peaked at $2.55M in Q4 2023.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.